Zhengkang Luo

Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Luo, Zhengkang; Mejia Cordova, Mariela; Hamze, Nour; Berggren, Elin et al.

Ingår i Endocrine, s. 626-637, 2024

• DOI för Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
• Ladda ner fulltext (pdf) av Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Diabetic complications and prospective immunotherapy

Reynolds, Lewis; Luo, Zhengkang; Singh, Kailash

Ingår i Frontiers in Immunology, 2023

• DOI för Diabetic complications and prospective immunotherapy
• Ladda ner fulltext (pdf) av Diabetic complications and prospective immunotherapy

Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Luo, Zhengkang

2023

• Ladda ner fulltext (pdf) av Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Luo, Zhengkang; Soläng, Charlotte; Larsson, Rasmus; Singh, Kailash

Ingår i International Journal of Molecular Sciences, 2022

• DOI för Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
• Ladda ner fulltext (pdf) av Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Singh, Kailash; Bricard, Orian; Haughton, Jeason; Björkqvist, Mikaela et al.

Ingår i Biomolecules, 2022

• DOI för Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
• Ladda ner fulltext (pdf) av Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Luo, Zhengkang; Mejia Cordova, Mariela; Hamze, Nour; Berggren, Elin et al.

Ingår i Endocrine, s. 626-637, 2024

• DOI för Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
• Ladda ner fulltext (pdf) av Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Luo, Zhengkang; Soläng, Charlotte; Larsson, Rasmus; Singh, Kailash

Ingår i International Journal of Molecular Sciences, 2022

• DOI för Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
• Ladda ner fulltext (pdf) av Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Singh, Kailash; Bricard, Orian; Haughton, Jeason; Björkqvist, Mikaela et al.

Ingår i Biomolecules, 2022

• DOI för Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
• Ladda ner fulltext (pdf) av Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Aspects of univalence in holographic axion models

Baggioli, Matteo; Grieninger, Sebastian; Grozdanov, Saso; Luo, Zhengkang

Ingår i Journal of High Energy Physics (JHEP), 2022

• DOI för Aspects of univalence in holographic axion models
• Ladda ner fulltext (pdf) av Aspects of univalence in holographic axion models

Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

Luo, Zhengkang; Lundin, Sara; Mejia Cordova, Mariela; Hassani, Imane et al.

Ingår i International Journal of Molecular Sciences, 2021

• DOI för Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
• Ladda ner fulltext (pdf) av Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

Significance of host heparanase in promoting tumor growth and metastasis

Zhang, Gan-Lin; Gutter-Kapon, Lilach; Ilan, Neta; Batool, Tahira et al.

Ingår i Matrix Biology, s. 25-42, 2020

• DOI för Significance of host heparanase in promoting tumor growth and metastasis

Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry

Luo, Zhengkang; Thorvaldson, Lina; Blixt, Martin; Singh, Kailash

Ingår i Journal of Visualized Experiments, 2019

• DOI för Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry

The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors

He, Qi; Li, Xiujuan; Singh, Kailash; Luo, Zhengkang et al.

Ingår i Scientific Reports, 2019

• DOI för The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
• Ladda ner fulltext 1 (pdf) av The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
• Ladda ner fulltext 2 (pdf) av The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors

Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes

Luo, Zhengkang; Soläng, Charlotte; Mejia Cordova, Mariela; Thorvaldson, Lina et al.

Ingår i FASEB BioAdvances, s. 538-549, 2019

• DOI för Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
• Ladda ner fulltext (pdf) av Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes

Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes

Singh, Kailash; Martinell, Mats; Luo, Zhengkang; Espes, Daniel et al.

Ingår i Clinical and Experimental Immunology, s. 64-73, 2019

• DOI för Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
• Ladda ner fulltext (pdf) av Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes

Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas

Li, Xiujuan; Singh, Kailash; Luo, Zhengkang; Mejia Cordova, Mariela et al.

Ingår i Oncotarget, s. 18720-18733, 2018

• DOI för Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
• Ladda ner fulltext (pdf) av Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas

Kinetics of innate immune and regulatory T cells responses in experimental diabetic nephropathy

Luo, Zhengkang; Varli, Sonya; Enström, Emma; Thorvaldson, Lina et al.

Ingår i Scandinavian Journal of Immunology, s. 304-304, 2017

Kinetics of the innate immune cell responses in experimental Type 1 Diabetes

Mejia Cordova, Mariela; Soläng, Charlotte; Luo, Zhengkang; Blixt, Martin et al.

Ingår i Scandinavian Journal of Immunology, s. 303-304, 2017

Diabetic complications and prospective immunotherapy

Reynolds, Lewis; Luo, Zhengkang; Singh, Kailash

Ingår i Frontiers in Immunology, 2023

• DOI för Diabetic complications and prospective immunotherapy
• Ladda ner fulltext (pdf) av Diabetic complications and prospective immunotherapy

Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Luo, Zhengkang

2023

• Ladda ner fulltext (pdf) av Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells